{ "kind": "all", "value": "all", "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations", "filters": { "documentKinds": [], "sourceTypes": [], "orientations": [] }, "total": 319975, "page": 1825, "pageSize": 60, "pageCount": 5333, "rows": [ { "docId": "019dd923-622b-71dc-a6da-8838cac54105", "docSlug": "385560c2d7f5", "documentTitle": "Fluor Corporation (FLR)", "authorId": "03_Starboard_Value", "authorName": "Starboard Value", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/6XGcHy0rF28fkG7hUdk3drd7qN-zu8KRYu3W6Lpc3jQ/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8zODU1NjBjMmQ3ZjUvcDAwMS5qcGc", "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622b-71dc-a6da-8838cac54105/1", "deckHref": "/decks/019dd923-622b-71dc-a6da-8838cac54105", "deckAnchorHref": "/decks/019dd923-622b-71dc-a6da-8838cac54105#slide-1", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": "https://imgproxy.kitesheet.com/apLgErhdP1Pr7IcLbzVR7iEbNNxNL1-oq05blEw9Kf8/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8zODU1NjBjMmQ3ZjUvcDAwMS5wbmc", "thumbSrc": "https://imgproxy.kitesheet.com/EvYNIbqqNqlV2_n6NWEUpBiI4r95QxSl8D-uz2xwRbg/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8zODU1NjBjMmQ3ZjUvcDAwMS5qcGc", "thumbSrcAlt": "https://imgproxy.kitesheet.com/5Xtyw7fBFb89zSCfvpCQsz2PqyEvVCSLxm5IC-yszvI/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8zODU1NjBjMmQ3ZjUvcDAwMS5wbmc" }, { "docId": "019dd923-622b-71dc-a6da-8838cac54105", "docSlug": "385560c2d7f5", "documentTitle": "Fluor Corporation (FLR)", "authorId": "03_Starboard_Value", "authorName": "Starboard Value", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622b-71dc-a6da-8838cac54105/2", "deckHref": "/decks/019dd923-622b-71dc-a6da-8838cac54105", "deckAnchorHref": "/decks/019dd923-622b-71dc-a6da-8838cac54105#slide-2", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622b-71dc-a6da-8838cac54105", "docSlug": "385560c2d7f5", "documentTitle": "Fluor Corporation (FLR)", "authorId": "03_Starboard_Value", "authorName": "Starboard Value", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "executive_summary", "function": "establish_context", "notes": "The slide uses a donut chart to represent the breakdown of the $28B YTD backlog by business segment.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622b-71dc-a6da-8838cac54105/3", "deckHref": "/decks/019dd923-622b-71dc-a6da-8838cac54105", "deckAnchorHref": "/decks/019dd923-622b-71dc-a6da-8838cac54105#slide-3", "loopMatches": [], "arcBeatMatches": [ { "to": 6, "from": 3, "beatId": "6d55ae6d-dae9-4d21-a661-fc3ee81f0f29", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Situation & Context", "beatSlug": "consultants-gambit-situation-context", "evidence": "The document sets the stage for its analysis, presenting Fluor's executive summary and segmentation", "position": 0, "confidence": 0.8, "parentBeatName": "Setup", "parentBeatSlug": "setup" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622b-71dc-a6da-8838cac54105", "docSlug": "385560c2d7f5", "documentTitle": "Fluor Corporation (FLR)", "authorId": "03_Starboard_Value", "authorName": "Starboard Value", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "segmentation", "function": "present_framework", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622b-71dc-a6da-8838cac54105/4", "deckHref": "/decks/019dd923-622b-71dc-a6da-8838cac54105", "deckAnchorHref": "/decks/019dd923-622b-71dc-a6da-8838cac54105#slide-4", "loopMatches": [], "arcBeatMatches": [ { "to": 6, "from": 3, "beatId": "6d55ae6d-dae9-4d21-a661-fc3ee81f0f29", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Situation & Context", "beatSlug": "consultants-gambit-situation-context", "evidence": "The document sets the stage for its analysis, presenting Fluor's executive summary and segmentation", "position": 0, "confidence": 0.8, "parentBeatName": "Setup", "parentBeatSlug": "setup" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622b-71dc-a6da-8838cac54105", "docSlug": "385560c2d7f5", "documentTitle": "Fluor Corporation (FLR)", "authorId": "03_Starboard_Value", "authorName": "Starboard Value", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "segmentation", "function": "present_framework", "notes": "The slide uses a grid-based layout to categorize business units and sub-sectors.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622b-71dc-a6da-8838cac54105/5", "deckHref": "/decks/019dd923-622b-71dc-a6da-8838cac54105", "deckAnchorHref": "/decks/019dd923-622b-71dc-a6da-8838cac54105#slide-5", "loopMatches": [], "arcBeatMatches": [ { "to": 6, "from": 3, "beatId": "6d55ae6d-dae9-4d21-a661-fc3ee81f0f29", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Situation & Context", "beatSlug": "consultants-gambit-situation-context", "evidence": "The document sets the stage for its analysis, presenting Fluor's executive summary and segmentation", "position": 0, "confidence": 0.8, "parentBeatName": "Setup", "parentBeatSlug": "setup" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622b-71dc-a6da-8838cac54105", "docSlug": "385560c2d7f5", "documentTitle": "Fluor Corporation (FLR)", "authorId": "03_Starboard_Value", "authorName": "Starboard Value", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "segmentation", "function": "decompose_segments", "notes": "The slide uses a grid-based segmentation to categorize business units.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622b-71dc-a6da-8838cac54105/6", "deckHref": "/decks/019dd923-622b-71dc-a6da-8838cac54105", "deckAnchorHref": "/decks/019dd923-622b-71dc-a6da-8838cac54105#slide-6", "loopMatches": [], "arcBeatMatches": [ { "to": 6, "from": 3, "beatId": "6d55ae6d-dae9-4d21-a661-fc3ee81f0f29", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Situation & Context", "beatSlug": "consultants-gambit-situation-context", "evidence": "The document sets the stage for its analysis, presenting Fluor's executive summary and segmentation", "position": 0, "confidence": 0.8, "parentBeatName": "Setup", "parentBeatSlug": "setup" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622b-71dc-a6da-8838cac54105", "docSlug": "385560c2d7f5", "documentTitle": "Fluor Corporation (FLR)", "authorId": "03_Starboard_Value", "authorName": "Starboard Value", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "competitive_analysis", "function": "compare_peers", "notes": "The slide uses a line chart to show market growth trends while listing competitors to illustrate market fragmentation.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622b-71dc-a6da-8838cac54105/7", "deckHref": "/decks/019dd923-622b-71dc-a6da-8838cac54105", "deckAnchorHref": "/decks/019dd923-622b-71dc-a6da-8838cac54105#slide-7", "loopMatches": [], "arcBeatMatches": [ { "to": 10, "from": 7, "beatId": "10d8d880-8918-41b2-9e8b-48f3270aa01e", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Problem & Complication", "beatSlug": "consultants-gambit-problem-complication", "evidence": "The document presents the competitive analysis and the problems with Fluor's previous business model", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622b-71dc-a6da-8838cac54105", "docSlug": "385560c2d7f5", "documentTitle": "Fluor Corporation (FLR)", "authorId": "03_Starboard_Value", "authorName": "Starboard Value", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "competitive_analysis", "function": "name_villain", "notes": "The slide uses a categorization framework to frame the market as inherently flawed and overly competitive.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622b-71dc-a6da-8838cac54105/8", "deckHref": "/decks/019dd923-622b-71dc-a6da-8838cac54105", "deckAnchorHref": "/decks/019dd923-622b-71dc-a6da-8838cac54105#slide-8", "loopMatches": [], "arcBeatMatches": [ { "to": 10, "from": 7, "beatId": "10d8d880-8918-41b2-9e8b-48f3270aa01e", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Problem & Complication", "beatSlug": "consultants-gambit-problem-complication", "evidence": "The document presents the competitive analysis and the problems with Fluor's previous business model", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622b-71dc-a6da-8838cac54105", "docSlug": "385560c2d7f5", "documentTitle": "Fluor Corporation (FLR)", "authorId": "03_Starboard_Value", "authorName": "Starboard Value", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "before_after", "function": "illustrate_case", "notes": "The chart uses a line graph with green and grey segments to denote different periods of Starboard's involvement.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622b-71dc-a6da-8838cac54105/9", "deckHref": "/decks/019dd923-622b-71dc-a6da-8838cac54105", "deckAnchorHref": "/decks/019dd923-622b-71dc-a6da-8838cac54105#slide-9", "loopMatches": [], "arcBeatMatches": [ { "to": 10, "from": 7, "beatId": "10d8d880-8918-41b2-9e8b-48f3270aa01e", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Problem & Complication", "beatSlug": "consultants-gambit-problem-complication", "evidence": "The document presents the competitive analysis and the problems with Fluor's previous business model", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622b-71dc-a6da-8838cac54105", "docSlug": "385560c2d7f5", "documentTitle": "Fluor Corporation (FLR)", "authorId": "03_Starboard_Value", "authorName": "Starboard Value", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "expose_contradiction", "function": "expose_contradiction", "notes": "The slide uses data to argue that previous management's strategy was unsuccessful.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622b-71dc-a6da-8838cac54105/10", "deckHref": "/decks/019dd923-622b-71dc-a6da-8838cac54105", "deckAnchorHref": "/decks/019dd923-622b-71dc-a6da-8838cac54105#slide-10", "loopMatches": [], "arcBeatMatches": [ { "to": 10, "from": 7, "beatId": "10d8d880-8918-41b2-9e8b-48f3270aa01e", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Problem & Complication", "beatSlug": "consultants-gambit-problem-complication", "evidence": "The document presents the competitive analysis and the problems with Fluor's previous business model", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622b-71dc-a6da-8838cac54105", "docSlug": "385560c2d7f5", "documentTitle": "Fluor Corporation (FLR)", "authorId": "03_Starboard_Value", "authorName": "Starboard Value", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "expose_contradiction", "function": "expose_contradiction", "notes": "The slide uses a combination of a bar chart for project losses and a line chart for stock performance to correlate operational failure with market valuation.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622b-71dc-a6da-8838cac54105/11", "deckHref": "/decks/019dd923-622b-71dc-a6da-8838cac54105", "deckAnchorHref": "/decks/019dd923-622b-71dc-a6da-8838cac54105#slide-11", "loopMatches": [], "arcBeatMatches": [ { "to": 14, "from": 11, "beatId": "00acd337-3cb7-42d0-9cd3-44dc2a734d56", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "The document presents evidence of Fluor's transformation and improved competitive dynamics", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622b-71dc-a6da-8838cac54105", "docSlug": "385560c2d7f5", "documentTitle": "Fluor Corporation (FLR)", "authorId": "03_Starboard_Value", "authorName": "Starboard Value", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "competitive_analysis", "function": "compare_peers", "notes": "The slide uses a logo-grid to categorize competitors into 'Current' and 'Past' (Bankruptcy/Distressed or Exit/Scaled Back).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622b-71dc-a6da-8838cac54105/12", "deckHref": "/decks/019dd923-622b-71dc-a6da-8838cac54105", "deckAnchorHref": "/decks/019dd923-622b-71dc-a6da-8838cac54105#slide-12", "loopMatches": [], "arcBeatMatches": [ { "to": 14, "from": 11, "beatId": "00acd337-3cb7-42d0-9cd3-44dc2a734d56", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "The document presents evidence of Fluor's transformation and improved competitive dynamics", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622b-71dc-a6da-8838cac54105", "docSlug": "385560c2d7f5", "documentTitle": "Fluor Corporation (FLR)", "authorId": "03_Starboard_Value", "authorName": "Starboard Value", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "before_after", "function": "analyze_data", "notes": "The chart highlights the period from FY21 onwards in green to signify the tenure of the new CEO.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622b-71dc-a6da-8838cac54105/13", "deckHref": "/decks/019dd923-622b-71dc-a6da-8838cac54105", "deckAnchorHref": "/decks/019dd923-622b-71dc-a6da-8838cac54105#slide-13", "loopMatches": [], "arcBeatMatches": [ { "to": 14, "from": 11, "beatId": "00acd337-3cb7-42d0-9cd3-44dc2a734d56", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "The document presents evidence of Fluor's transformation and improved competitive dynamics", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622b-71dc-a6da-8838cac54105", "docSlug": "385560c2d7f5", "documentTitle": "Fluor Corporation (FLR)", "authorId": "03_Starboard_Value", "authorName": "Starboard Value", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "before_after", "function": "analyze_data", "notes": "The chart tracks two metrics: 'Backlog for Ongoing Legacy Projects in Loss Position' and 'Estimated Unfunded Losses Associated with Ongoing Legacy Projects'.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622b-71dc-a6da-8838cac54105/14", "deckHref": "/decks/019dd923-622b-71dc-a6da-8838cac54105", "deckAnchorHref": "/decks/019dd923-622b-71dc-a6da-8838cac54105#slide-14", "loopMatches": [], "arcBeatMatches": [ { "to": 14, "from": 11, "beatId": "00acd337-3cb7-42d0-9cd3-44dc2a734d56", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "The document presents evidence of Fluor's transformation and improved competitive dynamics", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622b-71dc-a6da-8838cac54105", "docSlug": "385560c2d7f5", "documentTitle": "Fluor Corporation (FLR)", "authorId": "03_Starboard_Value", "authorName": "Starboard Value", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "competitive_analysis", "function": "compare_peers", "notes": "The slide uses a visual contrast between 'Prior EPCM Players' (greyed out/categorized by distress/exit) and 'Current EPCM Players' (highlighted in green).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622b-71dc-a6da-8838cac54105/15", "deckHref": "/decks/019dd923-622b-71dc-a6da-8838cac54105", "deckAnchorHref": "/decks/019dd923-622b-71dc-a6da-8838cac54105#slide-15", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622b-71dc-a6da-8838cac54105", "docSlug": "385560c2d7f5", "documentTitle": "Fluor Corporation (FLR)", "authorId": "03_Starboard_Value", "authorName": "Starboard Value", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "competitive_analysis", "function": "compare_peers", "notes": "The slide uses a line chart to illustrate market size trends while listing logos of competitors to establish the 'fragmented' nature of the market.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622b-71dc-a6da-8838cac54105/16", "deckHref": "/decks/019dd923-622b-71dc-a6da-8838cac54105", "deckAnchorHref": "/decks/019dd923-622b-71dc-a6da-8838cac54105#slide-16", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622b-71dc-a6da-8838cac54105", "docSlug": "385560c2d7f5", "documentTitle": "Fluor Corporation (FLR)", "authorId": "03_Starboard_Value", "authorName": "Starboard Value", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "competitive_analysis", "function": "compare_peers", "notes": "The slide uses a visual 'before and after' comparison of the competitive landscape to argue for Fluor's improved market position.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622b-71dc-a6da-8838cac54105/17", "deckHref": "/decks/019dd923-622b-71dc-a6da-8838cac54105", "deckAnchorHref": "/decks/019dd923-622b-71dc-a6da-8838cac54105#slide-17", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622b-71dc-a6da-8838cac54105", "docSlug": "385560c2d7f5", "documentTitle": "Fluor Corporation (FLR)", "authorId": "03_Starboard_Value", "authorName": "Starboard Value", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "before_after", "function": "analyze_data", "notes": "The chart illustrates a strategic shift in contract mix under CEO David Constable.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622b-71dc-a6da-8838cac54105/18", "deckHref": "/decks/019dd923-622b-71dc-a6da-8838cac54105", "deckAnchorHref": "/decks/019dd923-622b-71dc-a6da-8838cac54105#slide-18", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622b-71dc-a6da-8838cac54105", "docSlug": "385560c2d7f5", "documentTitle": "Fluor Corporation (FLR)", "authorId": "03_Starboard_Value", "authorName": "Starboard Value", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The chart uses CAGR annotations to show growth rates between periods.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622b-71dc-a6da-8838cac54105/19", "deckHref": "/decks/019dd923-622b-71dc-a6da-8838cac54105", "deckAnchorHref": "/decks/019dd923-622b-71dc-a6da-8838cac54105#slide-19", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622b-71dc-a6da-8838cac54105", "docSlug": "385560c2d7f5", "documentTitle": "Fluor Corporation (FLR)", "authorId": "03_Starboard_Value", "authorName": "Starboard Value", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 20, "slideType": "before_after", "function": "analyze_data", "notes": "The slide uses a before-after comparison of pie charts to illustrate strategic portfolio shift.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622b-71dc-a6da-8838cac54105/20", "deckHref": "/decks/019dd923-622b-71dc-a6da-8838cac54105", "deckAnchorHref": "/decks/019dd923-622b-71dc-a6da-8838cac54105#slide-20", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622b-71dc-a6da-8838cac54105", "docSlug": "385560c2d7f5", "documentTitle": "Fluor Corporation (FLR)", "authorId": "03_Starboard_Value", "authorName": "Starboard Value", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 21, "slideType": "cite_precedent", "function": "cite_precedent", "notes": "The slide uses a 'Truth Social' post as a form of authority citation to support the investment thesis.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622b-71dc-a6da-8838cac54105/21", "deckHref": "/decks/019dd923-622b-71dc-a6da-8838cac54105", "deckAnchorHref": "/decks/019dd923-622b-71dc-a6da-8838cac54105#slide-21", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622b-71dc-a6da-8838cac54105", "docSlug": "385560c2d7f5", "documentTitle": "Fluor Corporation (FLR)", "authorId": "03_Starboard_Value", "authorName": "Starboard Value", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 22, "slideType": "peer_benchmark", "function": "compare_peers", "notes": "The chart uses two distinct median lines for different peer groups. The footer contains a detailed disclaimer regarding methodology and data sources.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622b-71dc-a6da-8838cac54105/22", "deckHref": "/decks/019dd923-622b-71dc-a6da-8838cac54105", "deckAnchorHref": "/decks/019dd923-622b-71dc-a6da-8838cac54105#slide-22", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622b-71dc-a6da-8838cac54105", "docSlug": "385560c2d7f5", "documentTitle": "Fluor Corporation (FLR)", "authorId": "03_Starboard_Value", "authorName": "Starboard Value", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 23, "slideType": "valuation_reveal", "function": "show_valuation_bridge", "notes": "The calculation is presented as a simple arithmetic bridge: Market Cap * Ownership = Value.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622b-71dc-a6da-8838cac54105/23", "deckHref": "/decks/019dd923-622b-71dc-a6da-8838cac54105", "deckAnchorHref": "/decks/019dd923-622b-71dc-a6da-8838cac54105#slide-23", "loopMatches": [ { "to": 24, "from": 23, "name": "Iceberg", "slug": "10-iceberg", "bestFor": "Consulting, complex problem solving, organizational change", "matchId": "19674ac4-5c0c-416a-80be-2c89fbe3e91e", "evidence": "The document presents the valuation reveal of Fluor's NuScale stake", "position": 0, "objective": "To reveal the value of Fluor's NuScale stake", "structure": "The Symptom (Visible) -> The System (Hidden) -> The Root Cause", "confidence": 0.8, "description": "Reveal that the visible problem is merely a symptom of a deeper root cause" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622b-71dc-a6da-8838cac54105", "docSlug": "385560c2d7f5", "documentTitle": "Fluor Corporation (FLR)", "authorId": "03_Starboard_Value", "authorName": "Starboard Value", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 24, "slideType": "valuation_reveal", "function": "show_valuation_bridge", "notes": "The slide uses a waterfall-style bridge to demonstrate the impact of the NuScale stake on the valuation multiple.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622b-71dc-a6da-8838cac54105/24", "deckHref": "/decks/019dd923-622b-71dc-a6da-8838cac54105", "deckAnchorHref": "/decks/019dd923-622b-71dc-a6da-8838cac54105#slide-24", "loopMatches": [ { "to": 24, "from": 23, "name": "Iceberg", "slug": "10-iceberg", "bestFor": "Consulting, complex problem solving, organizational change", "matchId": "19674ac4-5c0c-416a-80be-2c89fbe3e91e", "evidence": "The document presents the valuation reveal of Fluor's NuScale stake", "position": 0, "objective": "To reveal the value of Fluor's NuScale stake", "structure": "The Symptom (Visible) -> The System (Hidden) -> The Root Cause", "confidence": 0.8, "description": "Reveal that the visible problem is merely a symptom of a deeper root cause" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622b-71dc-a6da-8838cac54105", "docSlug": "385560c2d7f5", "documentTitle": "Fluor Corporation (FLR)", "authorId": "03_Starboard_Value", "authorName": "Starboard Value", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 25, "slideType": "timeline", "function": "establish_context", "notes": "The slide uses a timeline framework to establish the long-term strategic relationship between Fluor and NuScale.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622b-71dc-a6da-8838cac54105/25", "deckHref": "/decks/019dd923-622b-71dc-a6da-8838cac54105", "deckAnchorHref": "/decks/019dd923-622b-71dc-a6da-8838cac54105#slide-25", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622b-71dc-a6da-8838cac54105", "docSlug": "385560c2d7f5", "documentTitle": "Fluor Corporation (FLR)", "authorId": "03_Starboard_Value", "authorName": "Starboard Value", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 26, "slideType": "other", "function": "present_solution", "notes": "The slide uses a process flow to explain the technology, highlighting the modular nature (77MW per module).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622b-71dc-a6da-8838cac54105/26", "deckHref": "/decks/019dd923-622b-71dc-a6da-8838cac54105", "deckAnchorHref": "/decks/019dd923-622b-71dc-a6da-8838cac54105#slide-26", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622b-71dc-a6da-8838cac54105", "docSlug": "385560c2d7f5", "documentTitle": "Fluor Corporation (FLR)", "authorId": "03_Starboard_Value", "authorName": "Starboard Value", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 27, "slideType": "competitive_analysis", "function": "compare_peers", "notes": "The slide uses a green dashed box to highlight NuScale as the primary subject of the comparison.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622b-71dc-a6da-8838cac54105/27", "deckHref": "/decks/019dd923-622b-71dc-a6da-8838cac54105", "deckAnchorHref": "/decks/019dd923-622b-71dc-a6da-8838cac54105#slide-27", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622b-71dc-a6da-8838cac54105", "docSlug": "385560c2d7f5", "documentTitle": "Fluor Corporation (FLR)", "authorId": "03_Starboard_Value", "authorName": "Starboard Value", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 28, "slideType": "thesis_headline", "function": "analyze_data", "notes": "The slide uses the performance data to justify a divestment argument by labeling the asset 'non-strategic'.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622b-71dc-a6da-8838cac54105/28", "deckHref": "/decks/019dd923-622b-71dc-a6da-8838cac54105", "deckAnchorHref": "/decks/019dd923-622b-71dc-a6da-8838cac54105#slide-28", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622b-71dc-a6da-8838cac54105", "docSlug": "385560c2d7f5", "documentTitle": "Fluor Corporation (FLR)", "authorId": "03_Starboard_Value", "authorName": "Starboard Value", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 29, "slideType": "thesis_headline", "function": "size_opportunity", "notes": "The slide uses a causal link (arrow) between rising data center power consumption and SMR investment.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622b-71dc-a6da-8838cac54105/29", "deckHref": "/decks/019dd923-622b-71dc-a6da-8838cac54105", "deckAnchorHref": "/decks/019dd923-622b-71dc-a6da-8838cac54105#slide-29", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622b-71dc-a6da-8838cac54105", "docSlug": "385560c2d7f5", "documentTitle": "Fluor Corporation (FLR)", "authorId": "03_Starboard_Value", "authorName": "Starboard Value", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 30, "slideType": "peer_benchmark", "function": "compare_peers", "notes": "The chart highlights a significant valuation gap between Fluor and its peers, with median multiples shown for different peer groups.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622b-71dc-a6da-8838cac54105/30", "deckHref": "/decks/019dd923-622b-71dc-a6da-8838cac54105", "deckAnchorHref": "/decks/019dd923-622b-71dc-a6da-8838cac54105#slide-30", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622b-71dc-a6da-8838cac54105", "docSlug": "385560c2d7f5", "documentTitle": "Fluor Corporation (FLR)", "authorId": "03_Starboard_Value", "authorName": "Starboard Value", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 31, "slideType": "valuation_reveal", "function": "show_valuation_bridge", "notes": "The chart specifically excludes the NuScale stake post-tax to isolate Fluor's core valuation.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622b-71dc-a6da-8838cac54105/31", "deckHref": "/decks/019dd923-622b-71dc-a6da-8838cac54105", "deckAnchorHref": "/decks/019dd923-622b-71dc-a6da-8838cac54105#slide-31", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622b-71dc-a6da-8838cac54105", "docSlug": "385560c2d7f5", "documentTitle": "Fluor Corporation (FLR)", "authorId": "03_Starboard_Value", "authorName": "Starboard Value", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 32, "slideType": "villain_critique", "function": "diagnose_problem", "notes": "Uses a combination of a line chart showing stock performance and direct quotes from executives to frame the problem.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622b-71dc-a6da-8838cac54105/32", "deckHref": "/decks/019dd923-622b-71dc-a6da-8838cac54105", "deckAnchorHref": "/decks/019dd923-622b-71dc-a6da-8838cac54105#slide-32", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622b-71dc-a6da-8838cac54105", "docSlug": "385560c2d7f5", "documentTitle": "Fluor Corporation (FLR)", "authorId": "03_Starboard_Value", "authorName": "Starboard Value", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 33, "slideType": "propose_solution", "function": "propose_solution", "notes": "The slide uses a binary classification (Taxable vs Tax-Free) to categorize strategic alternatives.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622b-71dc-a6da-8838cac54105/33", "deckHref": "/decks/019dd923-622b-71dc-a6da-8838cac54105", "deckAnchorHref": "/decks/019dd923-622b-71dc-a6da-8838cac54105#slide-33", "loopMatches": [], "arcBeatMatches": [ { "to": 34, "from": 33, "beatId": "70a29722-d994-4cc8-aa6c-208e3996ccb9", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution & Approach", "beatSlug": "consultants-gambit-solution-approach", "evidence": "The document proposes a solution for Fluor to unlock value by monetizing its NuScale stake", "position": 3, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622b-71dc-a6da-8838cac54105", "docSlug": "385560c2d7f5", "documentTitle": "Fluor Corporation (FLR)", "authorId": "03_Starboard_Value", "authorName": "Starboard Value", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 34, "slideType": "valuation_reveal", "function": "show_valuation_bridge", "notes": "The chart uses a bridge/waterfall structure to show the impact of removing the SMR stake on the EV/EBITDA multiple.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622b-71dc-a6da-8838cac54105/34", "deckHref": "/decks/019dd923-622b-71dc-a6da-8838cac54105", "deckAnchorHref": "/decks/019dd923-622b-71dc-a6da-8838cac54105#slide-34", "loopMatches": [], "arcBeatMatches": [ { "to": 34, "from": 33, "beatId": "70a29722-d994-4cc8-aa6c-208e3996ccb9", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution & Approach", "beatSlug": "consultants-gambit-solution-approach", "evidence": "The document proposes a solution for Fluor to unlock value by monetizing its NuScale stake", "position": 3, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622b-71dc-a6da-8838cac54105", "docSlug": "385560c2d7f5", "documentTitle": "Fluor Corporation (FLR)", "authorId": "03_Starboard_Value", "authorName": "Starboard Value", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 35, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622b-71dc-a6da-8838cac54105/35", "deckHref": "/decks/019dd923-622b-71dc-a6da-8838cac54105", "deckAnchorHref": "/decks/019dd923-622b-71dc-a6da-8838cac54105#slide-35", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622b-71dc-a6da-8cb69d3843ea", "docSlug": "436ccd4c75f6", "documentTitle": "Tripadvisor, Inc. (TRIP)", "authorId": "03_Starboard_Value", "authorName": "Starboard Value", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2025-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/eKKppW9uSnfXoEYioU5e7_QKK9-8ez78MCB3k4sFqB0/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy80MzZjY2Q0Yzc1ZjYvcDAwMS5qcGc", "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622b-71dc-a6da-8cb69d3843ea/1", "deckHref": "/decks/019dd923-622b-71dc-a6da-8cb69d3843ea", "deckAnchorHref": "/decks/019dd923-622b-71dc-a6da-8cb69d3843ea#slide-1", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 1, "beatId": "a2931ba8-13ec-4009-a575-ea51b7a64ae2", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Situation & Context", "beatSlug": "consultants-gambit-situation-context", "evidence": "Slides 1-5 provide an overview of Tripadvisor's current situation and context.", "position": 0, "confidence": 0.8, "parentBeatName": "Setup", "parentBeatSlug": "setup" } ], "imagePathAlt": "https://imgproxy.kitesheet.com/H79MdVM2jwqD7FEkiCmQrLhKlGwMVm0zeQjcRWpjE9w/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy80MzZjY2Q0Yzc1ZjYvcDAwMS5wbmc", "thumbSrc": "https://imgproxy.kitesheet.com/PtUiAk4GWb05MNuSc8Qs03fF2urU5I5wul7Rn6_Jvjo/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy80MzZjY2Q0Yzc1ZjYvcDAwMS5qcGc", "thumbSrcAlt": "https://imgproxy.kitesheet.com/IY7FX9Qxx9YmZqXcEVJRIoaYJZLo4Up-787AUgNTeCE/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy80MzZjY2Q0Yzc1ZjYvcDAwMS5wbmc" }, { "docId": "019dd923-622b-71dc-a6da-84595e2c37a3", "docSlug": "08680a75fcb3", "documentTitle": "Pfizer Inc. (PFE)", "authorId": "03_Starboard_Value", "authorName": "Starboard Value", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2024-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 51, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622b-71dc-a6da-84595e2c37a3/51", "deckHref": "/decks/019dd923-622b-71dc-a6da-84595e2c37a3", "deckAnchorHref": "/decks/019dd923-622b-71dc-a6da-84595e2c37a3#slide-51", "loopMatches": [ { "to": 73, "from": 10, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "28cefacd-d8d3-4ae9-ba09-ae3e05acdb07", "evidence": "The document highlights the potential costs of inaction for Pfizer, including continued underperformance and loss of value.", "position": 0, "objective": "What are the costs of inaction for Pfizer?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" }, { "to": 71, "from": 11, "name": "Mece Breakdown", "slug": "40-mece-breakdown", "bestFor": "Problem structuring, ensuring completeness, strategic analysis", "matchId": "02f3fffa-109d-4115-8a3f-00c62628d55f", "evidence": "The document proposes a breakdown of Pfizer's challenges and potential solutions.", "position": 1, "objective": "How can Pfizer improve its performance?", "structure": "The Whole -> Category A (distinct) -> Category B (distinct) -> Category C (distinct) -> Complete Coverage", "confidence": 0.7, "description": "Divide a complex topic into mutually exclusive, collectively exhaustive categories" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622b-71dc-a6da-84595e2c37a3", "docSlug": "08680a75fcb3", "documentTitle": "Pfizer Inc. (PFE)", "authorId": "03_Starboard_Value", "authorName": "Starboard Value", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2024-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 52, "slideType": "expose_contradiction", "function": "expose_contradiction", "notes": "The slide uses a red dashed box to isolate the 'COVID Benefit' period and another to highlight the summary statistics.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622b-71dc-a6da-84595e2c37a3/52", "deckHref": "/decks/019dd923-622b-71dc-a6da-84595e2c37a3", "deckAnchorHref": "/decks/019dd923-622b-71dc-a6da-84595e2c37a3#slide-52", "loopMatches": [ { "to": 73, "from": 10, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "28cefacd-d8d3-4ae9-ba09-ae3e05acdb07", "evidence": "The document highlights the potential costs of inaction for Pfizer, including continued underperformance and loss of value.", "position": 0, "objective": "What are the costs of inaction for Pfizer?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" }, { "to": 71, "from": 11, "name": "Mece Breakdown", "slug": "40-mece-breakdown", "bestFor": "Problem structuring, ensuring completeness, strategic analysis", "matchId": "02f3fffa-109d-4115-8a3f-00c62628d55f", "evidence": "The document proposes a breakdown of Pfizer's challenges and potential solutions.", "position": 1, "objective": "How can Pfizer improve its performance?", "structure": "The Whole -> Category A (distinct) -> Category B (distinct) -> Category C (distinct) -> Complete Coverage", "confidence": 0.7, "description": "Divide a complex topic into mutually exclusive, collectively exhaustive categories" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622b-71dc-a6da-84595e2c37a3", "docSlug": "08680a75fcb3", "documentTitle": "Pfizer Inc. (PFE)", "authorId": "03_Starboard_Value", "authorName": "Starboard Value", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2024-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 53, "slideType": "peer_benchmark", "function": "compare_peers", "notes": "The chart uses red bars to highlight Pfizer (PFE) and its 'Excl. COVID' performance, contrasting them with the blue bars of its peers.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622b-71dc-a6da-84595e2c37a3/53", "deckHref": "/decks/019dd923-622b-71dc-a6da-84595e2c37a3", "deckAnchorHref": "/decks/019dd923-622b-71dc-a6da-84595e2c37a3#slide-53", "loopMatches": [ { "to": 73, "from": 10, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "28cefacd-d8d3-4ae9-ba09-ae3e05acdb07", "evidence": "The document highlights the potential costs of inaction for Pfizer, including continued underperformance and loss of value.", "position": 0, "objective": "What are the costs of inaction for Pfizer?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" }, { "to": 71, "from": 11, "name": "Mece Breakdown", "slug": "40-mece-breakdown", "bestFor": "Problem structuring, ensuring completeness, strategic analysis", "matchId": "02f3fffa-109d-4115-8a3f-00c62628d55f", "evidence": "The document proposes a breakdown of Pfizer's challenges and potential solutions.", "position": 1, "objective": "How can Pfizer improve its performance?", "structure": "The Whole -> Category A (distinct) -> Category B (distinct) -> Category C (distinct) -> Complete Coverage", "confidence": 0.7, "description": "Divide a complex topic into mutually exclusive, collectively exhaustive categories" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622b-71dc-a6da-84595e2c37a3", "docSlug": "08680a75fcb3", "documentTitle": "Pfizer Inc. (PFE)", "authorId": "03_Starboard_Value", "authorName": "Starboard Value", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2024-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 54, "slideType": "expose_contradiction", "function": "expose_contradiction", "notes": "The slide uses red 'X' marks to visually emphasize the failure to meet expectations.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622b-71dc-a6da-84595e2c37a3/54", "deckHref": "/decks/019dd923-622b-71dc-a6da-84595e2c37a3", "deckAnchorHref": "/decks/019dd923-622b-71dc-a6da-84595e2c37a3#slide-54", "loopMatches": [ { "to": 73, "from": 10, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "28cefacd-d8d3-4ae9-ba09-ae3e05acdb07", "evidence": "The document highlights the potential costs of inaction for Pfizer, including continued underperformance and loss of value.", "position": 0, "objective": "What are the costs of inaction for Pfizer?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" }, { "to": 71, "from": 11, "name": "Mece Breakdown", "slug": "40-mece-breakdown", "bestFor": "Problem structuring, ensuring completeness, strategic analysis", "matchId": "02f3fffa-109d-4115-8a3f-00c62628d55f", "evidence": "The document proposes a breakdown of Pfizer's challenges and potential solutions.", "position": 1, "objective": "How can Pfizer improve its performance?", "structure": "The Whole -> Category A (distinct) -> Category B (distinct) -> Category C (distinct) -> Complete Coverage", "confidence": 0.7, "description": "Divide a complex topic into mutually exclusive, collectively exhaustive categories" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622b-71dc-a6da-84595e2c37a3", "docSlug": "08680a75fcb3", "documentTitle": "Pfizer Inc. (PFE)", "authorId": "03_Starboard_Value", "authorName": "Starboard Value", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2024-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 55, "slideType": "expose_contradiction", "function": "expose_contradiction", "notes": "The slide uses a bar chart to contrast historical performance with management's 2023 guidance, implying the guidance is overly optimistic given inventory levels.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622b-71dc-a6da-84595e2c37a3/55", "deckHref": "/decks/019dd923-622b-71dc-a6da-84595e2c37a3", "deckAnchorHref": "/decks/019dd923-622b-71dc-a6da-84595e2c37a3#slide-55", "loopMatches": [ { "to": 73, "from": 10, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "28cefacd-d8d3-4ae9-ba09-ae3e05acdb07", "evidence": "The document highlights the potential costs of inaction for Pfizer, including continued underperformance and loss of value.", "position": 0, "objective": "What are the costs of inaction for Pfizer?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" }, { "to": 71, "from": 11, "name": "Mece Breakdown", "slug": "40-mece-breakdown", "bestFor": "Problem structuring, ensuring completeness, strategic analysis", "matchId": "02f3fffa-109d-4115-8a3f-00c62628d55f", "evidence": "The document proposes a breakdown of Pfizer's challenges and potential solutions.", "position": 1, "objective": "How can Pfizer improve its performance?", "structure": "The Whole -> Category A (distinct) -> Category B (distinct) -> Category C (distinct) -> Complete Coverage", "confidence": 0.7, "description": "Divide a complex topic into mutually exclusive, collectively exhaustive categories" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622b-71dc-a6da-84595e2c37a3", "docSlug": "08680a75fcb3", "documentTitle": "Pfizer Inc. (PFE)", "authorId": "03_Starboard_Value", "authorName": "Starboard Value", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2024-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 56, "slideType": "expose_contradiction", "function": "expose_contradiction", "notes": "The slide uses a visual comparison of 'Doses Sold' vs 'Doses Used' to illustrate inventory dynamics and management's optimistic outlook.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622b-71dc-a6da-84595e2c37a3/56", "deckHref": "/decks/019dd923-622b-71dc-a6da-84595e2c37a3", "deckAnchorHref": "/decks/019dd923-622b-71dc-a6da-84595e2c37a3#slide-56", "loopMatches": [ { "to": 73, "from": 10, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "28cefacd-d8d3-4ae9-ba09-ae3e05acdb07", "evidence": "The document highlights the potential costs of inaction for Pfizer, including continued underperformance and loss of value.", "position": 0, "objective": "What are the costs of inaction for Pfizer?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" }, { "to": 71, "from": 11, "name": "Mece Breakdown", "slug": "40-mece-breakdown", "bestFor": "Problem structuring, ensuring completeness, strategic analysis", "matchId": "02f3fffa-109d-4115-8a3f-00c62628d55f", "evidence": "The document proposes a breakdown of Pfizer's challenges and potential solutions.", "position": 1, "objective": "How can Pfizer improve its performance?", "structure": "The Whole -> Category A (distinct) -> Category B (distinct) -> Category C (distinct) -> Complete Coverage", "confidence": 0.7, "description": "Divide a complex topic into mutually exclusive, collectively exhaustive categories" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622b-71dc-a6da-84595e2c37a3", "docSlug": "08680a75fcb3", "documentTitle": "Pfizer Inc. (PFE)", "authorId": "03_Starboard_Value", "authorName": "Starboard Value", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2024-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 57, "slideType": "expose_contradiction", "function": "expose_contradiction", "notes": "The slide uses a red-blue contrast to emphasize the negative performance gap.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622b-71dc-a6da-84595e2c37a3/57", "deckHref": "/decks/019dd923-622b-71dc-a6da-84595e2c37a3", "deckAnchorHref": "/decks/019dd923-622b-71dc-a6da-84595e2c37a3#slide-57", "loopMatches": [ { "to": 73, "from": 10, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "28cefacd-d8d3-4ae9-ba09-ae3e05acdb07", "evidence": "The document highlights the potential costs of inaction for Pfizer, including continued underperformance and loss of value.", "position": 0, "objective": "What are the costs of inaction for Pfizer?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" }, { "to": 71, "from": 11, "name": "Mece Breakdown", "slug": "40-mece-breakdown", "bestFor": "Problem structuring, ensuring completeness, strategic analysis", "matchId": "02f3fffa-109d-4115-8a3f-00c62628d55f", "evidence": "The document proposes a breakdown of Pfizer's challenges and potential solutions.", "position": 1, "objective": "How can Pfizer improve its performance?", "structure": "The Whole -> Category A (distinct) -> Category B (distinct) -> Category C (distinct) -> Complete Coverage", "confidence": 0.7, "description": "Divide a complex topic into mutually exclusive, collectively exhaustive categories" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622b-71dc-a6da-84595e2c37a3", "docSlug": "08680a75fcb3", "documentTitle": "Pfizer Inc. (PFE)", "authorId": "03_Starboard_Value", "authorName": "Starboard Value", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2024-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 58, "slideType": "expose_contradiction", "function": "expose_contradiction", "notes": "Uses red arrows to visually emphasize the gap between guidance and actuals, and the subsequent decline.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622b-71dc-a6da-84595e2c37a3/58", "deckHref": "/decks/019dd923-622b-71dc-a6da-84595e2c37a3", "deckAnchorHref": "/decks/019dd923-622b-71dc-a6da-84595e2c37a3#slide-58", "loopMatches": [ { "to": 73, "from": 10, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "28cefacd-d8d3-4ae9-ba09-ae3e05acdb07", "evidence": "The document highlights the potential costs of inaction for Pfizer, including continued underperformance and loss of value.", "position": 0, "objective": "What are the costs of inaction for Pfizer?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" }, { "to": 71, "from": 11, "name": "Mece Breakdown", "slug": "40-mece-breakdown", "bestFor": "Problem structuring, ensuring completeness, strategic analysis", "matchId": "02f3fffa-109d-4115-8a3f-00c62628d55f", "evidence": "The document proposes a breakdown of Pfizer's challenges and potential solutions.", "position": 1, "objective": "How can Pfizer improve its performance?", "structure": "The Whole -> Category A (distinct) -> Category B (distinct) -> Category C (distinct) -> Complete Coverage", "confidence": 0.7, "description": "Divide a complex topic into mutually exclusive, collectively exhaustive categories" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622b-71dc-a6da-84595e2c37a3", "docSlug": "08680a75fcb3", "documentTitle": "Pfizer Inc. (PFE)", "authorId": "03_Starboard_Value", "authorName": "Starboard Value", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2024-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 59, "slideType": "before_after", "function": "diagnose_problem", "notes": "The slide uses a waterfall-style gap visualization to emphasize the delta between market expectations and company guidance.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622b-71dc-a6da-84595e2c37a3/59", "deckHref": "/decks/019dd923-622b-71dc-a6da-84595e2c37a3", "deckAnchorHref": "/decks/019dd923-622b-71dc-a6da-84595e2c37a3#slide-59", "loopMatches": [ { "to": 73, "from": 10, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "28cefacd-d8d3-4ae9-ba09-ae3e05acdb07", "evidence": "The document highlights the potential costs of inaction for Pfizer, including continued underperformance and loss of value.", "position": 0, "objective": "What are the costs of inaction for Pfizer?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" }, { "to": 71, "from": 11, "name": "Mece Breakdown", "slug": "40-mece-breakdown", "bestFor": "Problem structuring, ensuring completeness, strategic analysis", "matchId": "02f3fffa-109d-4115-8a3f-00c62628d55f", "evidence": "The document proposes a breakdown of Pfizer's challenges and potential solutions.", "position": 1, "objective": "How can Pfizer improve its performance?", "structure": "The Whole -> Category A (distinct) -> Category B (distinct) -> Category C (distinct) -> Complete Coverage", "confidence": 0.7, "description": "Divide a complex topic into mutually exclusive, collectively exhaustive categories" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622b-71dc-a6da-84595e2c37a3", "docSlug": "08680a75fcb3", "documentTitle": "Pfizer Inc. (PFE)", "authorId": "03_Starboard_Value", "authorName": "Starboard Value", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2024-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 60, "slideType": "testimonial", "function": "expose_contradiction", "notes": "The slide uses quotes from Wolfe, JP Morgan, and TD Cowen to build a case against management.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622b-71dc-a6da-84595e2c37a3/60", "deckHref": "/decks/019dd923-622b-71dc-a6da-84595e2c37a3", "deckAnchorHref": "/decks/019dd923-622b-71dc-a6da-84595e2c37a3#slide-60", "loopMatches": [ { "to": 73, "from": 10, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "28cefacd-d8d3-4ae9-ba09-ae3e05acdb07", "evidence": "The document highlights the potential costs of inaction for Pfizer, including continued underperformance and loss of value.", "position": 0, "objective": "What are the costs of inaction for Pfizer?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" }, { "to": 71, "from": 11, "name": "Mece Breakdown", "slug": "40-mece-breakdown", "bestFor": "Problem structuring, ensuring completeness, strategic analysis", "matchId": "02f3fffa-109d-4115-8a3f-00c62628d55f", "evidence": "The document proposes a breakdown of Pfizer's challenges and potential solutions.", "position": 1, "objective": "How can Pfizer improve its performance?", "structure": "The Whole -> Category A (distinct) -> Category B (distinct) -> Category C (distinct) -> Complete Coverage", "confidence": 0.7, "description": "Divide a complex topic into mutually exclusive, collectively exhaustive categories" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622b-71dc-a6da-84595e2c37a3", "docSlug": "08680a75fcb3", "documentTitle": "Pfizer Inc. (PFE)", "authorId": "03_Starboard_Value", "authorName": "Starboard Value", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2024-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 61, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622b-71dc-a6da-84595e2c37a3/61", "deckHref": "/decks/019dd923-622b-71dc-a6da-84595e2c37a3", "deckAnchorHref": "/decks/019dd923-622b-71dc-a6da-84595e2c37a3#slide-61", "loopMatches": [ { "to": 73, "from": 10, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "28cefacd-d8d3-4ae9-ba09-ae3e05acdb07", "evidence": "The document highlights the potential costs of inaction for Pfizer, including continued underperformance and loss of value.", "position": 0, "objective": "What are the costs of inaction for Pfizer?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" }, { "to": 71, "from": 11, "name": "Mece Breakdown", "slug": "40-mece-breakdown", "bestFor": "Problem structuring, ensuring completeness, strategic analysis", "matchId": "02f3fffa-109d-4115-8a3f-00c62628d55f", "evidence": "The document proposes a breakdown of Pfizer's challenges and potential solutions.", "position": 1, "objective": "How can Pfizer improve its performance?", "structure": "The Whole -> Category A (distinct) -> Category B (distinct) -> Category C (distinct) -> Complete Coverage", "confidence": 0.7, "description": "Divide a complex topic into mutually exclusive, collectively exhaustive categories" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622b-71dc-a6da-84595e2c37a3", "docSlug": "08680a75fcb3", "documentTitle": "Pfizer Inc. (PFE)", "authorId": "03_Starboard_Value", "authorName": "Starboard Value", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2024-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 62, "slideType": "ceo_quote", "function": "cite_precedent", "notes": "The slide uses a quote-based argument to align the activist investor's thesis with management's stated goals.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622b-71dc-a6da-84595e2c37a3/62", "deckHref": "/decks/019dd923-622b-71dc-a6da-84595e2c37a3", "deckAnchorHref": "/decks/019dd923-622b-71dc-a6da-84595e2c37a3#slide-62", "loopMatches": [ { "to": 73, "from": 10, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "28cefacd-d8d3-4ae9-ba09-ae3e05acdb07", "evidence": "The document highlights the potential costs of inaction for Pfizer, including continued underperformance and loss of value.", "position": 0, "objective": "What are the costs of inaction for Pfizer?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" }, { "to": 71, "from": 11, "name": "Mece Breakdown", "slug": "40-mece-breakdown", "bestFor": "Problem structuring, ensuring completeness, strategic analysis", "matchId": "02f3fffa-109d-4115-8a3f-00c62628d55f", "evidence": "The document proposes a breakdown of Pfizer's challenges and potential solutions.", "position": 1, "objective": "How can Pfizer improve its performance?", "structure": "The Whole -> Category A (distinct) -> Category B (distinct) -> Category C (distinct) -> Complete Coverage", "confidence": 0.7, "description": "Divide a complex topic into mutually exclusive, collectively exhaustive categories" }, { "to": 73, "from": 62, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "c59431c8-0af0-4e90-9758-ec528e713b8a", "evidence": "The document highlights potential areas for improvement and growth.", "position": 2, "objective": "What are the potential quick wins and big bets for Pfizer?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 73, "from": 62, "beatId": "a59926c3-5c53-408e-b52d-295dfb9b624a", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document proposes potential solutions, including focusing on R&D and innovation, improving capital allocation, and holding management accountable.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622b-71dc-a6da-84595e2c37a3", "docSlug": "08680a75fcb3", "documentTitle": "Pfizer Inc. (PFE)", "authorId": "03_Starboard_Value", "authorName": "Starboard Value", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2024-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 63, "slideType": "expose_contradiction", "function": "expose_gap", "notes": "The chart uses a visual callout to quantify the 132 percentage point gap between Pfizer and the S&P 500.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622b-71dc-a6da-84595e2c37a3/63", "deckHref": "/decks/019dd923-622b-71dc-a6da-84595e2c37a3", "deckAnchorHref": "/decks/019dd923-622b-71dc-a6da-84595e2c37a3#slide-63", "loopMatches": [ { "to": 73, "from": 10, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "28cefacd-d8d3-4ae9-ba09-ae3e05acdb07", "evidence": "The document highlights the potential costs of inaction for Pfizer, including continued underperformance and loss of value.", "position": 0, "objective": "What are the costs of inaction for Pfizer?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" }, { "to": 71, "from": 11, "name": "Mece Breakdown", "slug": "40-mece-breakdown", "bestFor": "Problem structuring, ensuring completeness, strategic analysis", "matchId": "02f3fffa-109d-4115-8a3f-00c62628d55f", "evidence": "The document proposes a breakdown of Pfizer's challenges and potential solutions.", "position": 1, "objective": "How can Pfizer improve its performance?", "structure": "The Whole -> Category A (distinct) -> Category B (distinct) -> Category C (distinct) -> Complete Coverage", "confidence": 0.7, "description": "Divide a complex topic into mutually exclusive, collectively exhaustive categories" }, { "to": 73, "from": 62, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "c59431c8-0af0-4e90-9758-ec528e713b8a", "evidence": "The document highlights potential areas for improvement and growth.", "position": 2, "objective": "What are the potential quick wins and big bets for Pfizer?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 73, "from": 62, "beatId": "a59926c3-5c53-408e-b52d-295dfb9b624a", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document proposes potential solutions, including focusing on R&D and innovation, improving capital allocation, and holding management accountable.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622b-71dc-a6da-84595e2c37a3", "docSlug": "08680a75fcb3", "documentTitle": "Pfizer Inc. (PFE)", "authorId": "03_Starboard_Value", "authorName": "Starboard Value", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2024-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 64, "slideType": "expose_contradiction", "function": "expose_contradiction", "notes": "The slide uses a table from Pfizer's own Q1-2019 presentation to point out programs marked with 'X' (discontinued) or other delays, framing them as evidence of failure.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622b-71dc-a6da-84595e2c37a3/64", "deckHref": "/decks/019dd923-622b-71dc-a6da-84595e2c37a3", "deckAnchorHref": "/decks/019dd923-622b-71dc-a6da-84595e2c37a3#slide-64", "loopMatches": [ { "to": 73, "from": 10, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "28cefacd-d8d3-4ae9-ba09-ae3e05acdb07", "evidence": "The document highlights the potential costs of inaction for Pfizer, including continued underperformance and loss of value.", "position": 0, "objective": "What are the costs of inaction for Pfizer?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" }, { "to": 71, "from": 11, "name": "Mece Breakdown", "slug": "40-mece-breakdown", "bestFor": "Problem structuring, ensuring completeness, strategic analysis", "matchId": "02f3fffa-109d-4115-8a3f-00c62628d55f", "evidence": "The document proposes a breakdown of Pfizer's challenges and potential solutions.", "position": 1, "objective": "How can Pfizer improve its performance?", "structure": "The Whole -> Category A (distinct) -> Category B (distinct) -> Category C (distinct) -> Complete Coverage", "confidence": 0.7, "description": "Divide a complex topic into mutually exclusive, collectively exhaustive categories" }, { "to": 73, "from": 62, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "c59431c8-0af0-4e90-9758-ec528e713b8a", "evidence": "The document highlights potential areas for improvement and growth.", "position": 2, "objective": "What are the potential quick wins and big bets for Pfizer?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 73, "from": 62, "beatId": "a59926c3-5c53-408e-b52d-295dfb9b624a", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document proposes potential solutions, including focusing on R&D and innovation, improving capital allocation, and holding management accountable.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622b-71dc-a6da-84595e2c37a3", "docSlug": "08680a75fcb3", "documentTitle": "Pfizer Inc. (PFE)", "authorId": "03_Starboard_Value", "authorName": "Starboard Value", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2024-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 65, "slideType": "thesis_headline", "function": "establish_context", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622b-71dc-a6da-84595e2c37a3/65", "deckHref": "/decks/019dd923-622b-71dc-a6da-84595e2c37a3", "deckAnchorHref": "/decks/019dd923-622b-71dc-a6da-84595e2c37a3#slide-65", "loopMatches": [ { "to": 73, "from": 10, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "28cefacd-d8d3-4ae9-ba09-ae3e05acdb07", "evidence": "The document highlights the potential costs of inaction for Pfizer, including continued underperformance and loss of value.", "position": 0, "objective": "What are the costs of inaction for Pfizer?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" }, { "to": 71, "from": 11, "name": "Mece Breakdown", "slug": "40-mece-breakdown", "bestFor": "Problem structuring, ensuring completeness, strategic analysis", "matchId": "02f3fffa-109d-4115-8a3f-00c62628d55f", "evidence": "The document proposes a breakdown of Pfizer's challenges and potential solutions.", "position": 1, "objective": "How can Pfizer improve its performance?", "structure": "The Whole -> Category A (distinct) -> Category B (distinct) -> Category C (distinct) -> Complete Coverage", "confidence": 0.7, "description": "Divide a complex topic into mutually exclusive, collectively exhaustive categories" }, { "to": 73, "from": 62, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "c59431c8-0af0-4e90-9758-ec528e713b8a", "evidence": "The document highlights potential areas for improvement and growth.", "position": 2, "objective": "What are the potential quick wins and big bets for Pfizer?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 73, "from": 62, "beatId": "a59926c3-5c53-408e-b52d-295dfb9b624a", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document proposes potential solutions, including focusing on R&D and innovation, improving capital allocation, and holding management accountable.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622b-71dc-a6da-84595e2c37a3", "docSlug": "08680a75fcb3", "documentTitle": "Pfizer Inc. (PFE)", "authorId": "03_Starboard_Value", "authorName": "Starboard Value", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2024-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 66, "slideType": "peer_benchmark", "function": "compare_peers", "notes": "The chart highlights Pfizer (PFE) in red, showing it has the lowest return among the peer group.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622b-71dc-a6da-84595e2c37a3/66", "deckHref": "/decks/019dd923-622b-71dc-a6da-84595e2c37a3", "deckAnchorHref": "/decks/019dd923-622b-71dc-a6da-84595e2c37a3#slide-66", "loopMatches": [ { "to": 73, "from": 10, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "28cefacd-d8d3-4ae9-ba09-ae3e05acdb07", "evidence": "The document highlights the potential costs of inaction for Pfizer, including continued underperformance and loss of value.", "position": 0, "objective": "What are the costs of inaction for Pfizer?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" }, { "to": 71, "from": 11, "name": "Mece Breakdown", "slug": "40-mece-breakdown", "bestFor": "Problem structuring, ensuring completeness, strategic analysis", "matchId": "02f3fffa-109d-4115-8a3f-00c62628d55f", "evidence": "The document proposes a breakdown of Pfizer's challenges and potential solutions.", "position": 1, "objective": "How can Pfizer improve its performance?", "structure": "The Whole -> Category A (distinct) -> Category B (distinct) -> Category C (distinct) -> Complete Coverage", "confidence": 0.7, "description": "Divide a complex topic into mutually exclusive, collectively exhaustive categories" }, { "to": 73, "from": 62, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "c59431c8-0af0-4e90-9758-ec528e713b8a", "evidence": "The document highlights potential areas for improvement and growth.", "position": 2, "objective": "What are the potential quick wins and big bets for Pfizer?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 73, "from": 62, "beatId": "a59926c3-5c53-408e-b52d-295dfb9b624a", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document proposes potential solutions, including focusing on R&D and innovation, improving capital allocation, and holding management accountable.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622b-71dc-a6da-84595e2c37a3", "docSlug": "08680a75fcb3", "documentTitle": "Pfizer Inc. (PFE)", "authorId": "03_Starboard_Value", "authorName": "Starboard Value", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2024-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 67, "slideType": "valuation_reveal", "function": "expose_gap", "notes": "Uses a simple division framework to highlight capital allocation inefficiency.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622b-71dc-a6da-84595e2c37a3/67", "deckHref": "/decks/019dd923-622b-71dc-a6da-84595e2c37a3", "deckAnchorHref": "/decks/019dd923-622b-71dc-a6da-84595e2c37a3#slide-67", "loopMatches": [ { "to": 73, "from": 10, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "28cefacd-d8d3-4ae9-ba09-ae3e05acdb07", "evidence": "The document highlights the potential costs of inaction for Pfizer, including continued underperformance and loss of value.", "position": 0, "objective": "What are the costs of inaction for Pfizer?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" }, { "to": 71, "from": 11, "name": "Mece Breakdown", "slug": "40-mece-breakdown", "bestFor": "Problem structuring, ensuring completeness, strategic analysis", "matchId": "02f3fffa-109d-4115-8a3f-00c62628d55f", "evidence": "The document proposes a breakdown of Pfizer's challenges and potential solutions.", "position": 1, "objective": "How can Pfizer improve its performance?", "structure": "The Whole -> Category A (distinct) -> Category B (distinct) -> Category C (distinct) -> Complete Coverage", "confidence": 0.7, "description": "Divide a complex topic into mutually exclusive, collectively exhaustive categories" }, { "to": 73, "from": 62, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "c59431c8-0af0-4e90-9758-ec528e713b8a", "evidence": "The document highlights potential areas for improvement and growth.", "position": 2, "objective": "What are the potential quick wins and big bets for Pfizer?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 73, "from": 62, "beatId": "a59926c3-5c53-408e-b52d-295dfb9b624a", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document proposes potential solutions, including focusing on R&D and innovation, improving capital allocation, and holding management accountable.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622b-71dc-a6da-84595e2c37a3", "docSlug": "08680a75fcb3", "documentTitle": "Pfizer Inc. (PFE)", "authorId": "03_Starboard_Value", "authorName": "Starboard Value", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2024-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 68, "slideType": "revenue_buildup", "function": "show_valuation_bridge", "notes": "The slide uses a waterfall bridge to argue that current management's projected revenue return (15%) is insufficient compared to the target (38%).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622b-71dc-a6da-84595e2c37a3/68", "deckHref": "/decks/019dd923-622b-71dc-a6da-84595e2c37a3", "deckAnchorHref": "/decks/019dd923-622b-71dc-a6da-84595e2c37a3#slide-68", "loopMatches": [ { "to": 73, "from": 10, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "28cefacd-d8d3-4ae9-ba09-ae3e05acdb07", "evidence": "The document highlights the potential costs of inaction for Pfizer, including continued underperformance and loss of value.", "position": 0, "objective": "What are the costs of inaction for Pfizer?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" }, { "to": 71, "from": 11, "name": "Mece Breakdown", "slug": "40-mece-breakdown", "bestFor": "Problem structuring, ensuring completeness, strategic analysis", "matchId": "02f3fffa-109d-4115-8a3f-00c62628d55f", "evidence": "The document proposes a breakdown of Pfizer's challenges and potential solutions.", "position": 1, "objective": "How can Pfizer improve its performance?", "structure": "The Whole -> Category A (distinct) -> Category B (distinct) -> Category C (distinct) -> Complete Coverage", "confidence": 0.7, "description": "Divide a complex topic into mutually exclusive, collectively exhaustive categories" }, { "to": 73, "from": 62, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "c59431c8-0af0-4e90-9758-ec528e713b8a", "evidence": "The document highlights potential areas for improvement and growth.", "position": 2, "objective": "What are the potential quick wins and big bets for Pfizer?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 73, "from": 62, "beatId": "a59926c3-5c53-408e-b52d-295dfb9b624a", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document proposes potential solutions, including focusing on R&D and innovation, improving capital allocation, and holding management accountable.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622b-71dc-a6da-84595e2c37a3", "docSlug": "08680a75fcb3", "documentTitle": "Pfizer Inc. (PFE)", "authorId": "03_Starboard_Value", "authorName": "Starboard Value", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2024-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 69, "slideType": "revenue_buildup", "function": "quantify_opportunity", "notes": "Uses a waterfall-style logic to derive an incremental revenue requirement of $29 billion.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622b-71dc-a6da-84595e2c37a3/69", "deckHref": "/decks/019dd923-622b-71dc-a6da-84595e2c37a3", "deckAnchorHref": "/decks/019dd923-622b-71dc-a6da-84595e2c37a3#slide-69", "loopMatches": [ { "to": 73, "from": 10, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "28cefacd-d8d3-4ae9-ba09-ae3e05acdb07", "evidence": "The document highlights the potential costs of inaction for Pfizer, including continued underperformance and loss of value.", "position": 0, "objective": "What are the costs of inaction for Pfizer?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" }, { "to": 71, "from": 11, "name": "Mece Breakdown", "slug": "40-mece-breakdown", "bestFor": "Problem structuring, ensuring completeness, strategic analysis", "matchId": "02f3fffa-109d-4115-8a3f-00c62628d55f", "evidence": "The document proposes a breakdown of Pfizer's challenges and potential solutions.", "position": 1, "objective": "How can Pfizer improve its performance?", "structure": "The Whole -> Category A (distinct) -> Category B (distinct) -> Category C (distinct) -> Complete Coverage", "confidence": 0.7, "description": "Divide a complex topic into mutually exclusive, collectively exhaustive categories" }, { "to": 73, "from": 62, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "c59431c8-0af0-4e90-9758-ec528e713b8a", "evidence": "The document highlights potential areas for improvement and growth.", "position": 2, "objective": "What are the potential quick wins and big bets for Pfizer?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 73, "from": 62, "beatId": "a59926c3-5c53-408e-b52d-295dfb9b624a", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document proposes potential solutions, including focusing on R&D and innovation, improving capital allocation, and holding management accountable.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622b-71dc-a6da-84595e2c37a3", "docSlug": "08680a75fcb3", "documentTitle": "Pfizer Inc. (PFE)", "authorId": "03_Starboard_Value", "authorName": "Starboard Value", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2024-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 70, "slideType": "revenue_buildup", "function": "show_valuation_bridge", "notes": "The chart uses a waterfall bridge format to show the impact of LOEs and growth on 2030 revenue projections.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622b-71dc-a6da-84595e2c37a3/70", "deckHref": "/decks/019dd923-622b-71dc-a6da-84595e2c37a3", "deckAnchorHref": "/decks/019dd923-622b-71dc-a6da-84595e2c37a3#slide-70", "loopMatches": [ { "to": 73, "from": 10, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "28cefacd-d8d3-4ae9-ba09-ae3e05acdb07", "evidence": "The document highlights the potential costs of inaction for Pfizer, including continued underperformance and loss of value.", "position": 0, "objective": "What are the costs of inaction for Pfizer?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" }, { "to": 71, "from": 11, "name": "Mece Breakdown", "slug": "40-mece-breakdown", "bestFor": "Problem structuring, ensuring completeness, strategic analysis", "matchId": "02f3fffa-109d-4115-8a3f-00c62628d55f", "evidence": "The document proposes a breakdown of Pfizer's challenges and potential solutions.", "position": 1, "objective": "How can Pfizer improve its performance?", "structure": "The Whole -> Category A (distinct) -> Category B (distinct) -> Category C (distinct) -> Complete Coverage", "confidence": 0.7, "description": "Divide a complex topic into mutually exclusive, collectively exhaustive categories" }, { "to": 73, "from": 62, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "c59431c8-0af0-4e90-9758-ec528e713b8a", "evidence": "The document highlights potential areas for improvement and growth.", "position": 2, "objective": "What are the potential quick wins and big bets for Pfizer?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 73, "from": 62, "beatId": "a59926c3-5c53-408e-b52d-295dfb9b624a", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document proposes potential solutions, including focusing on R&D and innovation, improving capital allocation, and holding management accountable.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622b-71dc-a6da-84595e2c37a3", "docSlug": "08680a75fcb3", "documentTitle": "Pfizer Inc. (PFE)", "authorId": "03_Starboard_Value", "authorName": "Starboard Value", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2024-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 71, "slideType": "problem_statement", "function": "diagnose_problem", "notes": "Includes a causal flow diagram showing the link between achieving a 38% return and specific 2030 financial outcomes.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622b-71dc-a6da-84595e2c37a3/71", "deckHref": "/decks/019dd923-622b-71dc-a6da-84595e2c37a3", "deckAnchorHref": "/decks/019dd923-622b-71dc-a6da-84595e2c37a3#slide-71", "loopMatches": [ { "to": 73, "from": 10, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "28cefacd-d8d3-4ae9-ba09-ae3e05acdb07", "evidence": "The document highlights the potential costs of inaction for Pfizer, including continued underperformance and loss of value.", "position": 0, "objective": "What are the costs of inaction for Pfizer?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" }, { "to": 71, "from": 11, "name": "Mece Breakdown", "slug": "40-mece-breakdown", "bestFor": "Problem structuring, ensuring completeness, strategic analysis", "matchId": "02f3fffa-109d-4115-8a3f-00c62628d55f", "evidence": "The document proposes a breakdown of Pfizer's challenges and potential solutions.", "position": 1, "objective": "How can Pfizer improve its performance?", "structure": "The Whole -> Category A (distinct) -> Category B (distinct) -> Category C (distinct) -> Complete Coverage", "confidence": 0.7, "description": "Divide a complex topic into mutually exclusive, collectively exhaustive categories" }, { "to": 73, "from": 62, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "c59431c8-0af0-4e90-9758-ec528e713b8a", "evidence": "The document highlights potential areas for improvement and growth.", "position": 2, "objective": "What are the potential quick wins and big bets for Pfizer?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 73, "from": 62, "beatId": "a59926c3-5c53-408e-b52d-295dfb9b624a", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document proposes potential solutions, including focusing on R&D and innovation, improving capital allocation, and holding management accountable.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622b-71dc-a6da-84595e2c37a3", "docSlug": "08680a75fcb3", "documentTitle": "Pfizer Inc. (PFE)", "authorId": "03_Starboard_Value", "authorName": "Starboard Value", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2024-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 72, "slideType": "key_messages", "function": "state_demand", "notes": "This is a classic activist investor slide calling for board intervention in capital allocation.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622b-71dc-a6da-84595e2c37a3/72", "deckHref": "/decks/019dd923-622b-71dc-a6da-84595e2c37a3", "deckAnchorHref": "/decks/019dd923-622b-71dc-a6da-84595e2c37a3#slide-72", "loopMatches": [ { "to": 73, "from": 10, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "28cefacd-d8d3-4ae9-ba09-ae3e05acdb07", "evidence": "The document highlights the potential costs of inaction for Pfizer, including continued underperformance and loss of value.", "position": 0, "objective": "What are the costs of inaction for Pfizer?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" }, { "to": 73, "from": 62, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "c59431c8-0af0-4e90-9758-ec528e713b8a", "evidence": "The document highlights potential areas for improvement and growth.", "position": 2, "objective": "What are the potential quick wins and big bets for Pfizer?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 73, "from": 62, "beatId": "a59926c3-5c53-408e-b52d-295dfb9b624a", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document proposes potential solutions, including focusing on R&D and innovation, improving capital allocation, and holding management accountable.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622b-71dc-a6da-84595e2c37a3", "docSlug": "08680a75fcb3", "documentTitle": "Pfizer Inc. (PFE)", "authorId": "03_Starboard_Value", "authorName": "Starboard Value", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2024-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 73, "slideType": "peer_benchmark", "function": "compare_peers", "notes": "The chart highlights Pfizer's valuation gap relative to peers, suggesting undervaluation.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622b-71dc-a6da-84595e2c37a3/73", "deckHref": "/decks/019dd923-622b-71dc-a6da-84595e2c37a3", "deckAnchorHref": "/decks/019dd923-622b-71dc-a6da-84595e2c37a3#slide-73", "loopMatches": [ { "to": 73, "from": 10, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "28cefacd-d8d3-4ae9-ba09-ae3e05acdb07", "evidence": "The document highlights the potential costs of inaction for Pfizer, including continued underperformance and loss of value.", "position": 0, "objective": "What are the costs of inaction for Pfizer?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" }, { "to": 73, "from": 62, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "c59431c8-0af0-4e90-9758-ec528e713b8a", "evidence": "The document highlights potential areas for improvement and growth.", "position": 2, "objective": "What are the potential quick wins and big bets for Pfizer?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 73, "from": 62, "beatId": "a59926c3-5c53-408e-b52d-295dfb9b624a", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document proposes potential solutions, including focusing on R&D and innovation, improving capital allocation, and holding management accountable.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622b-71dc-a6da-84595e2c37a3", "docSlug": "08680a75fcb3", "documentTitle": "Pfizer Inc. (PFE)", "authorId": "03_Starboard_Value", "authorName": "Starboard Value", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2024-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 74, "slideType": "cover", "function": "front_matter", "notes": "Includes the company logo and website URL.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622b-71dc-a6da-84595e2c37a3/74", "deckHref": "/decks/019dd923-622b-71dc-a6da-84595e2c37a3", "deckAnchorHref": "/decks/019dd923-622b-71dc-a6da-84595e2c37a3#slide-74", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true } ] }